Verition Fund Management
SIOX

Verition Fund Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Verition Fund Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,000
Closed -$6K – 3083
2022
Q3 		$6K Hold
20,000
– – ﹤0.01% 2929
2022
Q2 		$7K Hold
20,000
– – ﹤0.01% 2256
2022
Q1 		$13K Hold
20,000
– – ﹤0.01% 2640
2021
Q4 		$26K Hold
20,000
– – ﹤0.01% 2466
2021
Q3 		$43K Hold
20,000
– – ﹤0.01% 1789
2021
Q2 		$55K Sell
20,000
-234,684
-92% -$583K ﹤0.01% 1796
2021
Q1 		$665K Hold
254,684
– – 0.01% 738
2020
Q4 		$708K Buy
254,684
+244,684
+2,447% +$712K 0.01% 573
2020
Q3 		$46K Buy
+10,000
New +$33K ﹤0.01% 1007

Other funds holding SIOX

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $674M AUM 24.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return